نتایج جستجو برای: روش mds

تعداد نتایج: 376977  

2013
Xiaoru Yuan Zuchao Wang Cong Guo

In this work, we propose MDS-Tree and MDS-Matrix as novel high dimensional data visualization methods to gain insight in both the data aspect and dimension aspect of the data. Dimension metrics of the high dimensional dataset are first computed to create a hierarchy. In an MDS-Tree, each node is an MDS projection of the original data items on a specific subset of dimensions associated with the ...

Journal: :Clinical and experimental rheumatology 2006
Y Tada S Koarada Y Haruta M Mitamura A Ohta K Nagasawa

OBJECTIVE [corrected] To determine the clinical characteristics of patients with myelodysplastic syndrome (MDS)-associated Behçet's disease (BD) in Japan. METHODS 54 Japanese cases of MDS-associated BD obtained from the literature and from our own clinical experience were reviewed. The clinical features of MDS-associated BD were compared with those of the 1991 nationwide BD survey in Japan. ...

Journal: :Molecular Cytogenetics 2021

Abstract Background Myelodysplastic syndrome (MDS), a heterogeneous group of hematopoietic malignancy, has been shown to present different cytogenetic abnormalities, risk factors, and clinico-hematological features in populations geographic areas. Herein, we determined the spectrum Iranian MDS patients for first time. Methods This prospective cross-sectional study was conducted on 103 with Ahva...

Linear diffusion layer is an important part of lightweight block ciphers and hash functions. This paper presents an efficient class of lightweight 4x4 MDS matrices such that the implementation cost of them and their corresponding inverses are equal. The main target of the paper is hardware oriented cryptographic primitives and the implementation cost is measured in terms of the required number ...

2017
Nahla A M Hamed

The morphologic dysplasia manifested in any lineage(s) frequently does not correlate with the specific cytopenia(s) in individual MDS cases. For this reason, WHO revision for adult MDS classification in 2016 removes terms such as “refractory anemia” and “refractory cytopenia” and replaces them with “myelodysplastic syndrome” followed by the appropriate modifiers: single vs multilineage dysplasi...

Journal: :Stem cell research 2015
F G J Calkoen C Vervat M van Pel V de Haas L S Vijfhuizen E Eising W G M Kroes P A C 't Hoen M M van den Heuvel-Eibrink R M Egeler M J D van Tol L M Ball

Pediatric myelodysplastic syndrome (MDS) is a heterogeneous disease covering a spectrum ranging from aplasia (RCC) to myeloproliferation (RAEB(t)). In adult-type MDS there is increasing evidence for abnormal function of the bone-marrow microenvironment. Here, we extensively studied the mesenchymal stromal cells (MSCs) derived from children with MDS. MSCs were expanded from the bone-marrow of 17...

Journal: :Blood 2016
Marcin W Wlodarski Shinsuke Hirabayashi Victor Pastor Jan Starý Henrik Hasle Riccardo Masetti Michael Dworzak Markus Schmugge Marry van den Heuvel-Eibrink Marek Ussowicz Barbara De Moerloose Albert Catala Owen P Smith Petr Sedlacek Arjan C Lankester Marco Zecca Victoria Bordon Susanne Matthes-Martin Jonas Abrahamsson Jörn Sven Kühl Karl-Walter Sykora Michael H Albert Bartlomiej Przychodzien Jaroslaw P Maciejewski Stephan Schwarz Gudrun Göhring Brigitte Schlegelberger Annámaria Cseh Peter Noellke Ayami Yoshimi Franco Locatelli Irith Baumann Brigitte Strahm Charlotte M Niemeyer

Germline GATA2 mutations cause cellular deficiencies with high propensity for myeloid disease. We investigated 426 children and adolescents with primary myelodysplastic syndrome (MDS) and 82 cases with secondary MDS enrolled in 2 consecutive prospective studies of the European Working Group of MDS in Childhood (EWOG-MDS) conducted in Germany over a period of 15 years. Germline GATA2 mutations a...

Journal: :Blood 2002
Maher Albitar Taghi Manshouri Yu Shen Diane Liu Miloslav Beran Hagop M Kantarjian Anna Rogers Iman Jilani Chung Wu Lin Sherry Pierce Emil J Freireich Elihu H Estey

Myelodysplastic syndrome (MDS) is a disease characterized by ineffective hematopoiesis. There are significant biologic and clinical differences between MDS and acute myeloid leukemia (AML). We studied a cohort of 802 patients, 279 (35%) with newly diagnosed MDS and 523 (65%) with newly diagnosed AML, and compared clinical and biologic characteristics of the 2 groups. Complete clinical and cytog...

آگاهی از ظرفیت خاک­ها برای بهره­برداری از آن‌ها در قالب انواع استفاده­های اصلی در اکوسیستم­های کشاورزی و منابع طبیعی مستلزم شناخت دقیق ویژگی­های فیزیکوشیمیایی و زیستی خاک می­باشد که تضمین کننده استفاده پایدار از اراضی می­باشد. لذا این تحقیق به منظور ارزیابی کیفیت خاک با استفاده از مدل‌های کمّی در اراضی کَنِ‌ سرخ شهرستان مهران به عنوان بخشی از اراضی خشک و نیمه‌خشک ایران در استان ایلام انجام شد. نمو...

Journal: :Blood 2008
Naoko Watanabe-Okochi Jiro Kitaura Ryoichi Ono Hironori Harada Yuka Harada Yukiko Komeno Hideaki Nakajima Tetsuya Nosaka Toshiya Inaba Toshio Kitamura

Myelodysplastic syndrome (MDS) is a hematopoietic stem-cell disorder characterized by trilineage dysplasia and susceptibility to acute myelogenous leukemia (AML). Analysis of molecular basis of MDS has been hampered by the heterogeneity of the disease. Recently, mutations of the transcription factor AML1/RUNX1 have been identified in 15% to 40% of MDS-refractory anemia with excess of blasts (RA...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید